Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based TNI BioTech has announced that its pharmaceutical sales division in Ireland, Airmed Biopharma (Airmed) has signed a non-exclusive distribution agreement with PanAm Global Logistics (PanAm) for marketing of Lodonal for cancer.
Subscribe to our email newsletter
As part of the deal, PanAm seeks to distribute a minimum of 5,000 ‘cartons’ per month, or 150,000 pills per month, for the balance of the year with sales expected to increase in 2015.
TNI BioTech has received first order for Lodonal in Africa and Airmed is responsible for servicing sales orders for the product in countries where TNI has received sales approval in Latin America and Africa.
According to the company, delivery of the shipment is expected to take place by 07 July 2014.
The agreement is expected to generate about $1,800,000 in revenue in year one of the distribution relationship.
TNI BioTech works to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system using the company’s patented immunotherapy.
The company’s products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.